Physician profile

Sonali Sethi

Pulmonary Disease · New York, NY

NPI 1053519058

$387,590.57

in general payments reported to CMS, 2019-2025

32 companies · $132K in 2025

The $132K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$141,609.63
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$62,500.00
Education$48,500.00
Travel and Lodging$32,787.10
Honoraria$21,423.90
Food and Beverage$16,046.59
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$5,925.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Noah Medical Corporation $209,380.60 2023-2025 Galaxy
Ambu A/S $64,138.97 2021-2025
US Endoscopy $40,159.00 2023-2025
Olympus America INC. $14,427.49 2023-2025 Eves Eus Ultrasound Bronchofibervideoscope, Vizishot 2 Flex, Single-Use Flexible Video Bronchoscope
Gyrus Acmi, INC. $12,310.27 2024-2025 Single-Use Flexible Video Bronchoscope, Spin Vision Video Processor
Steris Corporation $8,792.23 2022-2025
Intuitive Surgical, INC. $8,099.49 2022-2025 Da Vinci Surgical System
Olympus Corporation $7,711.69 2023
Ethicon INC. $5,925.79 2019-2025 Monarch Platform
Body Vision Medical INC. $3,805.51 2023-2024 Lungvision
Boston Scientific Corporation $2,818.47 2019-2024 Exalt Model D, Acquire, Spyglass Discover
Wilson Cook Medical Incorporated $2,481.25 2020
Pulmonx Corporation $1,530.18 2019-2022
Galvanize Therapeutics, INC $1,241.18 2022-2025 Aliya System
Getinge USA Sales, LLC $1,088.46 2019
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Olympus Medical Systems Corporation $990.00 2024
Covidien LP $519.49 2019
Veran Medical Technologies, INC. $440.00 2023 Spin Vision Video Processor
Atrium Medical Corporation $400.00 2020
Serpex Medical INC $250.22 2023-2024
Broncus Medical $177.07 2019
Philips North America LLC $171.10 2024 (Bi2) Igt Systems Undivided
Edwards Lifesciences Corporation $162.81 2025 Sapien 3 Ultra Resilia
Auris Health, INC. $121.49 2019
Medtronic, INC. $114.11 2024 Shiley, Illumisite
Cook Medical LLC $92.62 2022
Siemens Medical Solutions USA, INC. $83.67 2019
Acclarent, INC $80.57 2022
Olympus Corporation of The Americas $43.86 2022
Bard Peripheral Vascular, INC. $20.14 2021
Ambu INC. $12.84 2022

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sonali Sethi

$387,590.57

in general payments reported 2019-2025

Years
2019-2025
Top company
Noah Medical Corporation
Context
The $132K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/450358/sonali-sethi

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.